首页 | 本学科首页   官方微博 | 高级检索  
     

密蒙花方干预早期糖尿病视网膜病变初步疗效报告
引用本文:宋剑涛,高健生,接传红,严京,郭欣璐,赵丹丹,陈子燕,袁敏立. 密蒙花方干预早期糖尿病视网膜病变初步疗效报告[J]. 中国中医眼科杂志, 2010, 20(5)
作者姓名:宋剑涛  高健生  接传红  严京  郭欣璐  赵丹丹  陈子燕  袁敏立
作者单位:中国中医科学院眼科医院
基金项目:中国中医科学院优势病种
摘    要:目的初步评价密蒙花方改善非增殖期糖尿病视网膜病变(DR)视功能的有效性。方法采用随机对照临床试验研究方法,门诊收集66例DR患者,试验组(密蒙花组)33例,对照组(羟苯磺酸钙)33例,疗程3个月。治疗前及疗程结束检测视力、视野,同时检测肝肾功能等安全性指标。结果试验组治疗后与治疗前比较,视力、视野差异均有统计学意义(视力:t=6.707,P=0.0000.05,视野:t=4.322,P=0.0000.05);对照组治疗后视力与治疗前比较差异无统计学意义(t=1.752,P=0.0860.05),视野与治疗前比较差异有统计学意义(t=2.074,P=0.0430.05)。治疗过程中未发现肝肾功能损害。结论中药密蒙花方改善非增殖期DR视功能有效安全,疗效优于对照组。

关 键 词:密蒙花方  糖尿病  视网膜病变  视功能

Clinical report on early diabetic retinopathy interfered by Mimenghua Decoction
Affiliation:SONG Jiantao; GAO Jiansheng; JIE Chuanhong; et al. Eye hospital of China Academy of Chinese Medical Sciences; Beijing 100040; China;
Abstract:OBJECTIVE To evaluate the efficacy of Mimenghua Decoction in the treatment of visual function of nonproliferative diabetic retinopathy(DR). METHODS Designing randmized controlled clinical trials,there were 63 patients with nonproliferative DR who were enrolled and treated in Eye Hospital of China Academy of Chinese Medical Sciences with the same inclusion and exclusion criteria,Mimenghua Decoction group was 31 cases and calcium dobesilate group was 32 cases. Patients received periodic detailed ophthalmic ex...
Keywords:Mimenghua Decoction  diabetic retinopathy  visual function
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号